• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病运动症状和体征的评定量表:批判与建议

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

作者信息

Mestre Tiago A, Forjaz Maria João, Mahlknecht Philipp, Cardoso Francisco, Ferreira Joaquim J, Reilmann Ralf, Sampaio Cristina, Goetz Christopher G, Cubo Esther, Martinez-Martin Pablo, Stebbins Glenn T

机构信息

Division of Neurology Department of Medicine Parkinson's Disease and Movement Disorders Center The Ottawa Hospital Research Institute University of Ottawa Brain and Mind Institute Ottawa Canada.

Department of Epidemiology and Biostatistics National School of Public Health Carlos III Institute of Health and La Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) Madrid Spain.

出版信息

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

DOI:10.1002/mdc3.12571
PMID:30363393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6174417/
Abstract

Motor symptoms are a major feature of Huntington's disease (HD). The International Parkinson and Movement Disorder Society (MDS) commissioned the assessment of the clinimetric properties of motor rating scales in HD to make recommendations regarding their use, following previously established standardized criteria. After a systematic literature search, a total of 6 rating scales assessing motor symptoms and signs in HD were included for review. Performance testing (reviewed elsewhere) and quantitative motor rating methods were excluded. Only the Unified Huntington's Disease Rating Scale-Total Motor Score (UHDRS-TMS) was classified as "recommended" for assessing the severity of motor signs in HD. The following scales were classified as "suggested": Abnormal Involuntary Movement Scale, the UHDRS-TMS4, the Quantified Neurological Examination, and the Marsden and Quinn Chorea Severity Scale. The committee also concluded that further assessment of existing rating scales, including the UHDRS-TMS, is necessary to determine sensitivity to change and to screening for the presence of motor signs specific to HD. There is also a need to develop a motor rating scale to be used in positive gene carriers with subtle but not definite motor signs.

摘要

运动症状是亨廷顿舞蹈病(HD)的主要特征。国际帕金森和运动障碍协会(MDS)委托对HD运动评定量表的临床测量特性进行评估,以便按照先前制定的标准化标准就其使用提出建议。经过系统的文献检索,共纳入6个评估HD运动症状和体征的评定量表进行综述。性能测试(在其他地方进行综述)和定量运动评定方法被排除在外。只有统一亨廷顿舞蹈病评定量表-总运动评分(UHDRS-TMS)被归类为“推荐”用于评估HD运动体征的严重程度。以下量表被归类为“建议使用”:异常不自主运动量表、UHDRS-TMS4、定量神经学检查以及马斯登和奎因舞蹈症严重程度量表。委员会还得出结论,有必要对包括UHDRS-TMS在内的现有评定量表进行进一步评估,以确定对变化的敏感性以及筛查HD特有的运动体征。还需要开发一种运动评定量表,用于有轻微但不明确运动体征的阳性基因携带者。

相似文献

1
Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.亨廷顿舞蹈病运动症状和体征的评定量表:批判与建议
Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.
2
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.亨廷顿舞蹈症行为症状评定量表:评论与建议
Mov Disord. 2016 Oct;31(10):1466-1478. doi: 10.1002/mds.26675.
3
Rating scales for cognition in Huntington's disease: Critique and recommendations.亨廷顿病认知评定量表:评价与建议。
Mov Disord. 2018 Feb;33(2):187-195. doi: 10.1002/mds.27227. Epub 2017 Dec 26.
4
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.用于评估亨廷顿舞蹈症功能能力的评定量表和基于表现的测量方法:批判与建议
Mov Disord Clin Pract. 2018 May 9;5(4):361-372. doi: 10.1002/mdc3.12617. eCollection 2018 Jul-Aug.
5
Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.晚期亨廷顿病患者中统一亨廷顿病评定量表(UHDRS)和 UHDRS-晚期患者(UHDRS-FAP)的纵向评估。
Eur J Neurol. 2019 May;26(5):780-785. doi: 10.1111/ene.13889. Epub 2019 Jan 27.
6
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.疲劳评定量表:运动障碍学会帕金森病评定量表工作组的批评与建议。
Mov Disord. 2010 May 15;25(7):805-22. doi: 10.1002/mds.22989.
7
Predicting Severity of Huntington's Disease With Wearable Sensors.使用可穿戴传感器预测亨廷顿舞蹈症的严重程度。
Front Digit Health. 2022 Apr 4;4:874208. doi: 10.3389/fdgth.2022.874208. eCollection 2022.
8
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.工作组报告:评估帕金森病运动障碍的量表:批评与建议。
Mov Disord. 2010 Jul 15;25(9):1131-42. doi: 10.1002/mds.23072.
9
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.亨廷顿病的生活质量:评估患者健康相关生活质量和护理人员生活质量的测量方法的批判与建议。
Mov Disord. 2018 May;33(5):742-749. doi: 10.1002/mds.27317. Epub 2018 Mar 23.
10
Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.舌力分析评估了前驱期和有症状亨廷顿病的运动表型。
Mov Disord. 2010 Oct 15;25(13):2195-202. doi: 10.1002/mds.23243.

引用本文的文献

1
AI-Enhanced Transcriptomic Discovery of Druggable Targets and Repurposed Therapies for Huntington's Disease.人工智能助力亨廷顿舞蹈病可成药靶点及新疗法的转录组学发现
Brain Sci. 2025 Aug 14;15(8):865. doi: 10.3390/brainsci15080865.
2
Musical Distractions: Music-Based Rhythmic Auditory Stimulation Fails to Improve Gait in Huntington's Disease.音乐干扰:基于音乐的节奏听觉刺激未能改善亨廷顿舞蹈症患者的步态。
Brain Sci. 2025 Jul 31;15(8):820. doi: 10.3390/brainsci15080820.
3
Outcome measurement instruments in neurodegenerative diseases: Comprehensive analysis and platform construction.神经退行性疾病的疗效评估工具:综合分析与平台构建
Digit Health. 2025 Apr 17;11:20552076251335544. doi: 10.1177/20552076251335544. eCollection 2025 Jan-Dec.
4
Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.亨廷顿舞蹈症生物标志物的进展:十年文献计量分析与综合综述
Biology (Basel). 2025 Jan 26;14(2):129. doi: 10.3390/biology14020129.
5
Exploring relationships among gait, balance, and physical activity in individuals with Huntington's disease.探索亨廷顿舞蹈症患者的步态、平衡和身体活动之间的关系。
J Huntingtons Dis. 2024 Nov;13(4):557-568. doi: 10.1177/18796397241285000. Epub 2024 Sep 19.
6
Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from Enroll-HD.北美亨廷顿舞蹈症患者舞蹈症的纵向治疗模式:来自“入组-高清研究”(Enroll-HD)的数据
Neurol Ther. 2025 Jun;14(3):743-756. doi: 10.1007/s40120-024-00703-9. Epub 2025 Jan 15.
7
Comparing balance using the BESTest in Alzheimer, Huntington and Parkinson disease.比较阿尔茨海默病、亨廷顿病和帕金森病中使用 BESTest 的平衡情况。
Neurodegener Dis Manag. 2024;14(3-4):87-96. doi: 10.1080/17582024.2024.2388507. Epub 2024 Aug 19.
8
Unraveling progression subtypes in people with Huntington's disease.揭示亨廷顿舞蹈症患者的病情进展亚型。
EPMA J. 2024 May 28;15(2):275-287. doi: 10.1007/s13167-024-00368-2. eCollection 2024 Jun.
9
A Practical Guide for Clinical Approach to Patients With Huntington's Disease in Korea.韩国亨廷顿舞蹈病患者临床诊疗实用指南
J Mov Disord. 2024 Apr;17(2):138-149. doi: 10.14802/jmd.24040. Epub 2024 Mar 12.
10
Identification and Assessment of Outcome Measurement Instruments in Cauda Equina Syndrome: A Systematic Review.马尾综合征结局测量工具的识别与评估:一项系统综述
Global Spine J. 2024 Jul;14(6):1818-1826. doi: 10.1177/21925682241227916. Epub 2024 Jan 17.

本文引用的文献

1
Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.依西美坦治疗绝经后妇女晚期乳腺癌的临床观察
Mov Disord. 2015 Sep;30(10):1426-9. doi: 10.1002/mds.26308. Epub 2015 Jul 14.
2
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.利用临床和影像学指标预测明显亨廷顿病:一项前瞻性观察研究。
Lancet Neurol. 2014 Dec;13(12):1193-201. doi: 10.1016/S1474-4422(14)70238-8. Epub 2014 Nov 3.
3
Diagnostic criteria for Huntington's disease based on natural history.基于自然病史的亨廷顿舞蹈症诊断标准。
Mov Disord. 2014 Sep 15;29(11):1335-41. doi: 10.1002/mds.26011. Epub 2014 Aug 27.
4
Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.用于晚期患者的统一亨廷顿病评定量表:验证和随访研究。
Mov Disord. 2013 Oct;28(12):1717-23. doi: 10.1002/mds.25654.
5
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.TRACK-HD 研究中在无症状和早期亨廷顿病中表型进展和疾病发作的预测因素:36 个月观察性数据的分析。
Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.
6
The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.人胎纹状体组织双侧移植治疗轻中度亨廷顿病患者的长期安全性和有效性。
J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):657-65. doi: 10.1136/jnnp-2012-302441. Epub 2013 Jan 23.
7
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.TRACK-HD 研究中前驱期和早期亨廷顿病临床试验的潜在终点:24 个月观察数据的分析。
Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2.
8
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.TRACK-HD 研究中在前期和早期亨廷顿病中的生物学和临床变化:12 个月的纵向分析。
Lancet Neurol. 2011 Jan;10(1):31-42. doi: 10.1016/S1474-4422(10)70276-3. Epub 2010 Dec 2.
9
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.工作组报告:评估帕金森病运动障碍的量表:批评与建议。
Mov Disord. 2010 Jul 15;25(9):1131-42. doi: 10.1002/mds.23072.
10
Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness.亨廷顿舞蹈病运动和平衡障碍的临床测量:效度与反应性
Gait Posture. 2009 Apr;29(3):433-6. doi: 10.1016/j.gaitpost.2008.11.002. Epub 2008 Dec 25.